Mymetics presents new data regarding cold chain independent virosome based vaccines
On 6ix: 6ix.com/news/mymetics-presents-new-data-regarding-cold-chain-independent-virosome-based-vaccines-1
The original release is unavailable here.
Earlier from Mymetics
- New Mymetics data to be presented by LMIV at American Society of Tropical Medicine and Hygiene
- Mymetics Starts Research Collaboration Project in Cancer Immunotherapy with eTheRNA
- New Mymetics Data Regarding Cold Chain Independent Virosome Based Vaccines to be Presented at AAPS in Washington, D.C.
- DGAP-News: Anergis and Mymetics Start Research Collaboration Project on the use of Virosomes for Ultra-Fast Allergy Immunotherapy
- Mymetics to Present New Preclinical Data on Thermostable and Cold-Chain Independent Virosome based Vaccines
Later from Mymetics
- Mymetics Virosomes Successful in Allergy Proof-of-Concept Study
- Mymetics Receives Funding from NIH for Novel HIV Vaccine Study
- Mymetics receives HIV Vaccine Funding from the NIH
- Mymetics Announces New Study to Predict Efficacy of Second- Generation COP Allergy Immunotherpy with Virosomes
- Mymetics Annouces Publication in Npj Vaccines of preclinical study of malaria vaccine
Follow Mymetics into a list and get an email when it puts out news.
Follow Mymetics